AnaptysBio, Celgene in antibody deal

AnaptysBio Inc. (San Diego, Calif.) partnered with Celgene Corp. (NASDAQ:CELG) to develop antibodies against cancer and inflammation targets using AnaptysBio's SHM-XEL technology. Celgene will receive...